SILENCE THERAPEUTICS PLC-ADR (SLN)

US82686Q1013 - ADR

6.88  +0.54 (+8.52%)

After market: 6.54 -0.34 (-4.94%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth

-100.00%		244K5.479M
2,145.49%		10.128M
84.86%		24.617M
143.05%		30.798M
25.11%		15.779M
-48.77%		32.344M
104.98%
EBITDA
YoY % growth
-20.172M
-44.52%		-22.252M
-10.31%		-35.351M
-58.87%		N/AN/A-64.062M-75.086M
-17.21%		-39.729M
47.09%
EBIT
YoY % growth
-20.571M
-42.94%		-22.734M
-10.51%		-35.847M
-57.68%		N/A-44.262M-57.936M
-30.89%		-80.063M
-38.19%		-81.406M
-1.68%
Operating Margin
N/A-9,317.21%-654.26%N/A-179.80%-188.12%-507.40%-251.69%
EPS
YoY % growth
N/AN/A
-20,270.00%		-0.40
-89.69%		-0.50
-24.74%		-0.62
-25.00%		-0.33
46.06%		-0.36
-7.31%		-0.40
-10.53%

All data in GBP

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in GBP

Recent Earnings VS Estimates Surprises (GBP)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -1.10
-107,098.37%		%
Q4 2022
Q2Q % growth
99.39%		0.00%
Q2 2022
Q2Q % growth
10.55%		-0.20%
Q4 2021
Q2Q % growth
34.89%		-0.17%
Q2 2021
Q2Q % growth		 -0.23
-66.42%		-0.22-0.01-2.96%
Q4 2020
Q2Q % growth		 -0.26
-24.40%		-0.21-0.05-22.41%
Q2 2020
Q2Q % growth		 -0.14 -0.220.0938.71%
Q4 2019
Q2Q % growth
-20,270.00%		-0.21%
Recent Revenue VS Estimates Surprises (GBP)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth		 598K
-93.43%		%
Q1 2024
Q2Q % growth		 12.406M
9.07%		%
Q4 2023
Q2Q % growth		 2.04M
-57.18%		%
Q3 2023
Q2Q % growth		 2.798M
-17.00%		%
Q4 2022
Q2Q % growth		 4.765M
-11.03%		18.981M-14.216M-74.90%
Q2 2022
Q2Q % growth
-100.00%		%
Q4 2021
Q2Q % growth
23.61%		5.356M%
Q2 2021
Q2Q % growth		 5.845M
410.03%		5.845M%
Q4 2020
Q2Q % growth		 4.333M
1,675.82%		2.472M1.861M75.28%
Q2 2020
Q2Q % growth		 1.146M 1.854M-708K-38.19%
Q4 2019
Q2Q % growth		 244K 1.851M-1.607M-86.82%
Q4 2018
Q2Q % growth		 14.21M-14.21M-100.00%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A